[163188] in SIPB-AFS-requests
Bonus-No.49961641973 - Please-Claim Your Walgreens-Points Now.
daemon@ATHENA.MIT.EDU (WalgreensRewards)
Tue Mar 7 12:47:14 2017
From StacyDaniels@bonus.bonusnewestrewardsinfo.com Tue Mar 07 17:47:13 2017
Return-Path: <StacyDaniels@bonus.bonusnewestrewardsinfo.com>
Delivered-To: sipb-afsreq-mtg@charon.mit.edu
Received: (qmail 7438 invoked from network); 7 Mar 2017 17:47:13 -0000
Received: from amir.sunbloommarketing.com (HELO bonus.bonusnewestrewardsinfo.com) (199.116.119.133)
by charon.mit.edu with SMTP; 7 Mar 2017 17:47:13 -0000
Date: Tue, 07 Mar 2017 10:48:55 -0700
Content-Type: text/html; charset=UTF-8
Subject: Bonus-No.49961641973 - Please-Claim Your Walgreens-Points Now.
Message-ID: <h882d_8d8e2u4996164edg2-g8su14203892d3g.8h923@send.bonusnewestrewardsinfo.com>
Reply-To: WalgreensRewards@bonusnewestrewardsinfo.com
To: sipb-afsreq-mtg@charon.mit.edu
Content-transfer-encoding: 8bit
MIME-Version: 1.0
From: WalgreensRewards <WalgreensRewards@bonusnewestrewardsinfo.com>
Priority: Normal
<html>
<head>
<title>Bonus-Updates</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<style type="text/css">
#wwiogi9 {
font-family: "Times New Roman", Times, serif;
font-size: 22px;
font-weight: bold;
font-style: italic;
text-align: center;
}
#xkd82 {
font-family: "Times New Roman", Times, serif;
font-size: 15px;
text-align: center;
}
#dksgw812 {
font-family: "Times New Roman", Times, serif;
font-size: 16px;
text-align: center;
}
#sdig81 {
font-family: "Times New Roman", Times, serif;
font-size: 15px;
}
#wudghf8e {
font-family: "Times New Roman", Times, serif;
font-size: 7.9px;
}
</style>
</head>
<body bgcolor="#FFFFFF" leftmargin="0" topmargin="0" marginwidth="0" marginheight="0">
<table id="Table_01" width="600" height="584" border="0" cellpadding="0" cellspacing="0">
<tr>
<td width="373" id="wwiogi9">Your $50-Walgreens Reward!</td>
<td width="227" rowspan="3">
<a href="http://newreward.bonusnewestrewardsinfo.com"><img src="http://see1.bonusnewestrewardsinfo.com" width="223" height="317" alt=""></a></td>
</tr>
<tr>
<td id="xkd82"><br>
Hello sipb-afsreq-mtg@charon.mit.edu,<br></td>
</tr>
<tr>
<td id="dksgw812"><p><br>
If you want to get your $50-Walgreens Reward you need to act-fast because it will-expire at the end of the day this-friday!</p>
<p>Please simply-visit the link-below and take the short-survey that follows to redeem your bonus-now.</p>
<p style="font-weight: bold; font-style: italic;">Walgreens-Reward Notice No.49961645882</p>
<p><br>
<span style="font-weight: bold"><a href="http://newreward.bonusnewestrewardsinfo.com">Go Here to Get Your Walgreens-Points Right-Away</a></span></p></td>
</tr>
<tr>
<td colspan="2" id="sdig81"><p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p>*_You can.end these bonusads-if you would_rather by <a href="http://vweu7.bonusnewestrewardsinfo.com">going_here</a>.<br>
..-2885 Sanford-Avenue S.W. No.40442.<br>
Grandville.<br>
MlCHlGAN.<br>
ZIPCODE: #49418.</p>
<p> </p></td>
</tr>
<tr>
<td colspan="2" id="wudghf8e"><p> </p>
<p> </p>
<p>In the U.S., his retail strategy is to infuse the panache of Boots into the efficiency and convenience of Walgreens stores. As WBA bulks up, it is girding itself to take on giant CVS Health CVS -0.05% in the battle for control of consumers’ medicine chests. Can Pessina give its biggest U.S. rival a run for its money—or has the master acquirer finally done one deal too many? One bottle of San Pellegrino water. It’s the closest thing to a personal item visible in Pessina’s office in Walgreens Boots Alliance’s headquarters in Deerfield, Ill., near Chicago. It’s the only evidence that a human being at least occasionally works there. There are no photographs with luminaries, no mementos of product launches or even stacks of files. Perhaps that’s because Pessina actually lives in Monaco and spends so much time on the road. It may also be because he isn’t interested in typical CEO activities. He doesn’t visit many stores or pose for selfies with the employee of the month. He doesn’t obsess over a particular SKU. “I am not a retailer,” he readily admits. “I am not a wholesaler anymore. I am a team builder and a company builder.”</p>
<p>Pessina had never planned to be a businessman. He attended the prestigious Politecnico di Milano, intending to become a nuclear engineer or an academic. But during the turbulent late 1960s, he was repelled by his fellows students’ push for what he viewed as lax grading standards. “I was disgusted,” he says. He quit school and landed a job heading the statistical department of A.C. Nielsen’s Italy office. When Nielsen asked him to move to Chicago, he declined. “I had learned what I could learn,” he says.</p>
<p>Instead, he turned his attention to a project for his father, Oreste, who owned a small, struggling pharmaceutical wholesaler in Naples. Oreste hoped his son’s facility with numbers would help him. Pessina says he turned the business around—then began helping his father’s colleagues do the same in return for a small stake in their companies. He soon realized the sector was ripe for consolidation.</p>
<p>Pessina became enamored with transactions—so much so that in 1984 he fell for Ornella Barra, the glamorous owner of a small Ligurian drug wholesaler, whose company he later bought. The two never wed (Pessina remains married to his first wife, from whom he separated decades ago), but they are “life partners.” Barra has worked with Pessina ever since, holding senior executive positions in every iteration of his company. Today she heads Walgreens’ global wholesale and international retail divisions. Says Barra: “The secret of our life and working together is that he’s the boss. We have different opinions, but when he takes a decision, it’s also my decision.” After Italy, Pessina set his sights on France, where, with Barra at his side, he rolled up 30% of the drug-wholesaling market within five years and then moved into other countries. He became a master at understanding the quirks of each region, in part by partnering with—and then outmaneuvering—smaller players. His method: Buy a stake in a company, help improve the bottom line, and then gain enough control to merge with or buy yet another one. It always seemed he was buying a new company before he had even finished unwrapping the last one.</p>
<p>“It’s a game at the end of the day,” says Pessina, who estimates he has made 1,500 acquisitions. Adds Ken Murphy, a deputy for 17 years and the head of WBA’s global brands: “He’s got an objectivity which is quite stunning. He never gets emotionally embroiled; he never loses himself. He never becomes a slave to the deal.”</p>
<p>For all of Pessina’s seeming addiction to transactions, there was a broader strategy at work: He was convinced that the drug-distribution business was destined to consolidate. And so Pessina kept rolling up ever bigger targets. Alliance Santé, as his company was called by the mid-1990s, expanded further into Europe until 1997, when Pessina, believing he could rationalize the costs of pharmacies with his wholesale business, merged with UniChem, one of Britain’s largest pharmacy chains and a public company. The move added retail expertise and the experience of a public listing to his portfolio and made him wildly wealthy. Yet he struggled to integrate the two cultures—and, in a precursor of things to come, took over as CEO. (He relinquished the position in 2004.)</p>
<p>Next, Pessina boldly set his sights on Boots, the largest and best-loved English drugstore chain. He spent several frustrating years trying to persuade three different chief executives to sell. In 2005 he finally got CEO Richard Baker to take the bait. The companies combined to form the new Alliance Boots.</p>
<p>Although the European press often calls him “silver fox” for his spiky white hair and blue eyes, Pessina lacks charisma on first impression—until you ask him about a deal or the future of the industry. Then his eyes crackle with energy and he displays a penetrating clarity (not to mention a refreshing absence of CEO pablum). Pessina has maintained his focus, plowing his equity into the next deal. That’s one reason his fortune is currently estimated at more than $12 billion. He insists he’s not motivated by riches. “When you have some money,” he says, “if you have 10 times more, it’s absolutely irrelevant.” Pessina wants to keep building.</p>
<p> </p></td>
</tr>
</table>
<img src="http://trc.bonusnewestrewardsinfo.com/redirect.php?email=sipb-afsreq-mtg@charon.mit.edu">
</body>
</html>
